U.S. M&A: full speed ahead for 2019

By Troy Ungerman (Toronto) on December 18, 2018 Posted in M&A

Optimism is the name of the game for the U.S. M&A market. A recent report by Deloitte cites positive tax reform, a relaxed regulatory climate and growing cash reserves as the primary reasons for expecting 2019 to be a big year for M&A. 79% of the 1,000 U.S. corporate executives and private equity firms surveyed … Continue reading

A healthy dose of deal-making: M&A trends in the US and Canadian healthcare sector

By Troy Ungerman (Toronto) on May 3, 2018 Posted in M&A, Pharmaceuticals and life sciences

In the first quarter of 2018, M&A activity across the world hit a 17 year record high according to Mergermarket’s Q1 2018 Global M&A Report. This is an 18 percent increase in value compared to the first quarter of 2017. This increase was affected by the surge in deal-making seen at the end of 2017 … Continue reading

Investor confidence, disruption risk and US tax reform will continue to spur M&A activity

By Troy Ungerman (Toronto) on February 22, 2018 Posted in M&A, Tax

JP Morgan recently released its 2018 Global M&A Outlook report, predicting that 1) investor confidence from solid GDP growth, 2) disruption risk from technological change, and 3) opportunities from the passing of the US tax reform will drive significant M&A activity in the year ahead. Investor confidence In 2017, nine out of ten equity sectors … Continue reading